Alteration of behavior and monoamine levels attributable to Lactobacillus plantarum PS128 in germ-free mice

Probiotics, defined as live bacteria or bacterial products, confer a significant health benefit to the host, including amelioration of anxiety-like behavior and psychiatric illnesses. Here we administered Lactobacillus plantarum PS128 (PS128) to a germ-free (GF) mouse model to investigate the impact of the gut-brain axis on emotional behaviors. First, we demonstrated that chronic administration of live PS128 showed no adverse effects on physical health. Then, we found that administration of live PS128 significantly increased the total distance traveled in the open field test and decreased the time spent in the closed arm in the elevated plus maze test, whereas the administration of PS128 had no significant effects in the depression-like behaviors of GF mice. Also, chronic live PS128 ingestion significantly increased the levels of both serotonin and dopamine in the striatum, but not in the prefrontal cortex or hippocampus. These results suggest that the chronic administration of PS128 is safe and could induce changes in emotional behaviors. The behavioral changes are correlated with the increase in the monoamine neurotransmitters in the striatum. These findings suggest that daily intake of the L. plantarum strain PS128 could improve anxiety-like behaviors and may be helpful in ameliorating neuropsychiatric disorders.

[1]  Y. Chida,et al.  Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice , 2004, The Journal of physiology.

[2]  Rupert Lanzenberger,et al.  The Serotonin-1A Receptor in Anxiety Disorders , 2009, Biological Psychiatry.

[3]  K. Oishi,et al.  Effects of intraduodenal injection of Lactobacillus brevis SBC8803 on autonomic neurotransmission and appetite in rodents , 2013, Neuroscience Letters.

[4]  L. Desbonnet,et al.  The microbiome: stress, health and disease , 2013, Mammalian Genome.

[5]  M. Surette,et al.  The interplay between the intestinal microbiota and the brain , 2012, Nature Reviews Microbiology.

[6]  B. Berger,et al.  The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut–brain communication , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[7]  A. Ziomber,et al.  Chronic impairment of the vagus nerve function leads to inhibition of dopamine but not serotonin neurons in rat brain structures , 2012, Pharmacological reports : PR.

[8]  S. Prakash,et al.  In vitro and in vivo characterization and strain safety of Lactobacillus reuteri NCIMB 30253 for probiotic applications. , 2012, Canadian journal of microbiology.

[9]  A. Logan,et al.  Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part I – autointoxication revisited , 2013, Gut Pathogens.

[10]  L. Desbonnet,et al.  Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression , 2010, Neuroscience.

[11]  T. Dinan,et al.  Mind-altering Microorganisms: the Impact of the Gut Microbiota on Brain and Behaviour , 2022 .

[12]  E. Pehek,et al.  Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. , 2007, Pharmacology & therapeutics.

[13]  G. Burdock,et al.  Safety evaluation of Lactobacillus pentosus strain b240. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  P. Scully,et al.  The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner , 2013, Molecular Psychiatry.

[15]  Aldert L. Zomer,et al.  Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection , 2012, Proceedings of the National Academy of Sciences.

[16]  J. Foster,et al.  Reduced anxiety‐like behavior and central neurochemical change in germ‐free mice , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[17]  S. Hjorth,et al.  Local infusion of the selective 5HT‐1B agonist CP‐93,129 facilitates striatal dopamine release in vivo , 1993, Synapse.

[18]  H. Forssberg,et al.  Normal gut microbiota modulates brain development and behavior , 2011, Proceedings of the National Academy of Sciences.

[19]  M. Galloway,et al.  Serotonin-facilitated dopamine release in vivo: pharmacological characterization. , 1993, The Journal of pharmacology and experimental therapeutics.

[20]  J. Bienenstock,et al.  Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats , 2005, Gut.

[21]  P. Wong,et al.  Regulation of striatal dopamine release through 5‐HT1 and 5‐HT2 receptors , 1999 .

[22]  M. Messaoudi,et al.  Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects , 2010, British Journal of Nutrition.

[23]  John F. Cryan,et al.  Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve , 2011, Proceedings of the National Academy of Sciences.

[24]  O. Mabrouk,et al.  Amphetamine stimulates movement through thalamocortical glutamate release , 2014, Journal of neurochemistry.

[25]  wen ling ma,et al.  Behavioural Brain Research , 2016 .

[26]  Safety Evaluation of Multiple Strains of Lactobacillus plantarum and Pediococcus pentosaceus in Wistar Rats Based on the Ames Test and a 28-Day Feeding Study , 2014, TheScientificWorldJournal.

[27]  P. Kelly,et al.  Effects of dopamine receptor stimulants on locomotor activity of rats with electrolytic or 6-hydroxydopamine-induced lesions of the nucleus accumbens , 1976, Psychopharmacology.

[28]  M. Furuse,et al.  Commensal microbiota modulate murine behaviors in a strictly contamination‐free environment confirmed by culture‐based methods , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[29]  J. Nicholson,et al.  Host-Gut Microbiota Metabolic Interactions , 2012, Science.

[30]  M. Galloway,et al.  Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. , 1991, European journal of pharmacology.

[31]  T. Tsai,et al.  Determination of catecholamines in pheochromocytoma cell (PC-12) culture medium by microdialysis-microbore liquid chromatography. , 2000, Journal of chromatography. A.

[32]  Peter Vontobel,et al.  5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride , 1999, Neuropsychopharmacology.